Table-III.
QLQ-C30 scale score between two groups (point, Mean±SD).
| Influence factor | Effective (n=45) | Ineffective (n=35) | X2 | P | |
|---|---|---|---|---|---|
| Age | ≥60 | 11(24.4) | 13(37.1) | 0.749 | >0.05 |
| <60 | 34(75.6) | 22(62.9) | |||
| Gender | male | 31(68.9) | 20(57.1) | 0.407 | >0.05 |
| female | 14(31.1) | 15(42.9) | |||
| WBC | ≥4 (×109/ L) | 34(75.6) | 24(68.6) | 0.281 | >0.05 |
| <4 (×109/ L) | 11(24.4) | 11(31.4) | |||
| PLT | ≥100 (×109/ L) | 14(31.1) | 4(11.4) | 3.802 | >0.05 |
| <100 (×109/ L) | 31(68.9) | 31(88.6) | |||
| Hb | ≥90 g/L | 16(35.6) | 3(8.6) | 4.779 | <0.05 |
| <90 g/L | 29(64.4) | 32(91.4) | |||
| WHO staging | RAEB-1 | 19(42.2) | 27(77.1) | 6.011 | <0.05 |
| RAEB-2 | 26(57.8) | 8(22.9) | |||
| IPSS score | Low risk+medium risk | 29(64.4) | 20(57.1) | 0.488 | >0.05 |
| High risk | 16(35.6) | 15(42.9) | |||
| Chromosome karyotype | Good+moderate | 42(93.3) | 24(68.6) | 5.027 | <0.05 |
| Bad | 3(6.7) | 11(31.4) |